| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| CE Curtis Ellergodt Rothschild Investment LLC | 40 | $3.6 | $2.8 | -$0.8 | -22.22% |
George Soros Soros Fund Management LLC | 20,797 | $831.88 | $1,455.79 | $623.91 | 75% |
Point72 Asset Management LP Point72 Asset Management LP | 2M | $100,791.8 | $139,980.68 | $39,188.88 | 38.88% |
| YA Yinka Akinsola Blue Trust Inc. | 104 | $10.22 | $7.28 | -$2.94 | -28.77% |
| JA Jeff Ameen Spire Wealth Management | 5,000 | $491.5 | $350 | -$141.5 | -28.79% |
| Household Products Industry | Consumer Staples Sector | Robert F. Bartlett CEO | OTC PINK Exchange | 74623V103 CUSIP |
| US Country | - Employees | - Last Dividend | 15 Aug 2012 Last Split | 8 Aug 1996 IPO Date |
PURE Bioscience, Inc. is at the forefront of developing and commercializing innovative antimicrobial solutions, addressing both health and environmental challenges associated with pathogen and hygiene control globally. With a primary focus on manufacturing and distributing silver dihydrogen citrate (SDC), a groundbreaking non-toxic antimicrobial agent, PURE Bioscience has successfully introduced a range of SDC-based products catering to diverse sanitizing and disinfecting needs. Established in 1992, the company operates out of Rancho Cucamonga, California, offering its advanced solutions to various sectors, including food safety and facility hygiene, in the United States and internationally.